González-López J, González-Rojo P, Berenguer-Rubio A, et al. Optimisation of osteosarcoma sample processing for epigenetic analysis: A comparative evaluation of formalin-fixed, paraffin-embedded samples with and without decalcification versus fresh tissue. Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia. 2026;59(3):100881. doi:10.1016/j.patol.2026.100881
Specht E, Pakanati L, Wu MJ, et al. Loss of tumor-infiltrating lymphocytes and poor response to immunotherapy in IDH GOF mutant melanoma. JCI insight. 2026;11(11). doi:10.1172/jci.insight.195384
Madhulika S, Panda S, Samal P, et al. Dysregulated HELLS expression alters cellular processes and serves as a potential prognostic marker in acute myeloid leukemia. The Journal of biological chemistry. 2026:113210. doi:10.1016/j.jbc.2026.113210
Byrne SR, DeMott MS, Yuan Y, et al. Temporal dynamics and metagenomics of phosphorothioate epigenomes in the human gut microbiome. Microbiome. 2025;13(1):81. doi:10.1186/s40168-025-02071-4
Fang R, Vallius T, Zhang A, et al. PRAME expression in melanoma is negatively regulated by TET2-mediated DNA hydroxymethylation. Laboratory investigation; a journal of technical methods and pathology. 2025:104123. doi:10.1016/j.labinv.2025.104123
Catanese MC, Klingl YE, Gilbert TM, et al. Chemoproteomics Sheds Light on Epigenetic Targets of [C]Martinostat in the Human Brain. ACS chemical neuroscience. 2025. doi:10.1021/acschemneuro.4c00781
Catanese MC, Klingl YE, Gilbert TM, et al. Chemoproteomics Sheds Light on Epigenetic Targets of [C]Martinostat in the Human Brain. ACS chemical neuroscience. 2025. doi:10.1021/acschemneuro.4c00781
Kendsersky NM, Odrobina M, Mabe NW, et al. Lineage-dependence of the neuroblastoma surfaceome defines tumor cell state-dependent and independent immunotherapeutic targets. Neuro-oncology. 2025. doi:10.1093/neuonc/noaf012
Kendsersky NM, Odrobina M, Mabe NW, et al. Lineage-dependence of the neuroblastoma surfaceome defines tumor cell state-dependent and independent immunotherapeutic targets. Neuro-oncology. 2025. doi:10.1093/neuonc/noaf012
Kendsersky NM, Odrobina M, Mabe NW, et al. Lineage-dependence of the neuroblastoma surfaceome defines tumor cell state-dependent and independent immunotherapeutic targets. Neuro-oncology. 2025. doi:10.1093/neuonc/noaf012